ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer.

Shi-Ming Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.